Skip to main content
Fig. 2 | BMC Psychiatry

Fig. 2

From: Long-acting injectable antipsychotic (LAI) prescribing trends during COVID-19 restrictions in Canada: a retrospective observational study

Fig. 2

Average monthly rates of LAI new starts and LAI discontinuations, by epoch for national data. The numbers of new starts and discontinuations of LAI prescriptions are shown for nationwide data. These data reflect the number of unique patients based on the earliest switch event included in the study timeline, or in an epoch. Patients may have multiple switch events in the study or in a given epoch but are only counted once for this figure. LAI, long-acting injectable antipsychotic

Back to article page